Jonathan Peng is a Cardiology physician. OpenAlex indexes 8 publications with 949 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
34 Mark West Springs Rd Fl 3
Santa Rosa, CA 954031766
Telephone
707-573-5200Provider last certified this registry record 17 Jun 2023.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20254 payments
- Medtronic, Inc.Program year20253 payments
- HEARTFLOW, INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.9%Beta blocker22.1%Metoprolol Succinate49%Carvedilol27%Metoprolol Tartrate11%Bisoprolol Fumarate5%Sotalol3%Atenolol3%Sotalol Af2%Part D<11 patientsStatin17.9%Atorvastatin Calcium72%Rosuvastatin Calcium24%Pravastatin Sodium3%Part D<11 patients+ 13 more classes in this area
Blood & clotting
10.7%Factor Xa inhibitor9.2%Eliquis89%Xarelto11%Part D<11 patientsP2Y12 inhibitor1.5%Brilinta59%Clopidogrel41%Part D<11 patientsMetabolism & gastrointestinal
3.4%SGLT2 inhibitor3.4%Jardiance81%Farxiga19%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Short QT in a Cohort of 1.7 Million Persons: Prevalence, Correlates, and Prognosis
Annals of Noninvasive Electrocardiology
2014 - Validation of a population‐based method to assess drug‐induced alterations in the QT interval: a self‐controlled crossover study
Pharmacoepidemiology and Drug Safety
2013 - Usefulness of Fragmented QRS on a 12-Lead Electrocardiogram in Acute Coronary Syndrome for Predicting Mortality
The American Journal of Cardiology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”